Turkish FinTech company Matriks Bilgi Dagitim Hizmetleri A.S. (“Matriks”), whose software services are very well-known by the persons, professionals and institutions active in banking and finance industry, successfully completed an initial public offering (IPO) and was listed on Borsa Istanbul. This was a local IPO, targeting Turkish investors where individual shareholders sold 38.05% of Matriks shares along with share buy-back, lock-up and EBITDA commitments to investors.
Matriks is trading on Borsa Istanbul as of 6 April 2021 under the symbol of “MTRKS”. This IPO set the record of the highest book-building in Borsa Istanbul’s history by attracting demand of almost 700,000 investors as of the trading date. Strong and record level of investor demand is a good sign to increase the depth of Turkish capital markets and is a clear indication of investors’ trust and confidence in Matriks.
Paksoy is pleased to announce that the capital markets team led by Omer Collak (Partner) together with Ökkeş Şahan (Counsel), Nazlı Tönük Çapan (Senior Associate), Merve Kurdak Kurtdarcan (Associate) and Bülent Öztürk (Associate) acted as transaction counsel in this project.
Share
Related persons
You can contact us for detailed information.




Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
19 January 2026
Paksoy advises Amphenol on its acquisition of CommScope’s CCS business
Paksoy advises Amphenol Corporation on its acquisition of CommScope’s Connectivity and Cable Solutions (CCS) business.
14 January 2026
Paksoy advised Stellantis Group on the sale of BPF Pazarlama to TOFAŞ
Paksoy advised Stellantis Group on the sale of BPF Pazarlama to TOFAŞ.
13 January 2026
Paksoy advised IFC on its investment in Getmobil
Paksoy advised IFC on its investment in Getmobil.
12 January 2026
Mergermarket has ranked us #1 Legal Adviser in Turkey by deal value for 2025
Mergermarket has ranked us #1 Legal Adviser in Turkey by deal value for 2025, advising on USD 4.97 billion across 18 transactions.
7 January 2026
Paksoy advises Sanofi on the sale of a majority stake in its Lüleburgaz manufacturing facility
Paksoy advises Sanofi on the sale of a majority stake in its Lüleburgaz manufacturing facility.
5 January 2026
We are pleased to announce the promotion of Sabri Kaya to Counsel, effective as of 1 January 2026
We extend our congratulations to Sabri Kaya on his well-deserved promotion to Counsel.